Search
for
Sort by
Research 61–90 of 96
- The Biology and Genomics of Human Hair Follicles: A Focus on Androgenetic Alopecia
- Compliance to Topical Minoxidil and Reasons for Discontinuation among Patients with Androgenetic Alopecia
- Intermediate Hair Follicles from Patients with Female Pattern Hair Loss Are Associated with Nutrient Insufficiency and a Quiescent Metabolic Phenotype
- Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
- Megestrol Acetate Increases the Proliferation, Migration, and Adipogenic Differentiation of Adipose-Derived Stem Cells via Glucocorticoid Receptor
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Melatonin regulates the periodic growth of secondary hair follicles through the nuclear receptor RORα
- Application of multi-omics techniques to androgenetic alopecia: Current status and perspectives
- SULT1A1 (Minoxidil Sulfotransferase) enzyme booster significantly improves response to topical minoxidil for hair regrowth
- SULT1A1 enzyme booster to amplify topical minoxidil response in androgenic alopecia: a single-center prospective study
- Pilot study: genetic distribution of AR, FGF5, SULT1A1 and CYP3A5 polymorphisms in male Mexican population with androgenetic alopecia.
- Sulfotransferase SULT1A1 activity in hair follicle, a prognostic marker of response to the minoxidil treatment in patients with androgenetic alopecia: a review
- Novel enzymatic assay predicts minoxidil response in the treatment of androgenetic alopecia
- Co-delivery of Minoxidil and Tocopherol acetate Ethosomes to Reshape the Hair FolliculaMicroenvironment and Promote Hair Regeneration in Androgenetic Alopecia
- Minoxidil as a Prodrug: Review of Chemical, Pharmacological, and Technological Aspects in Alopecia Therapeutics
- Prognostic factors in the treatment of androgenetic alopecia with minoxidil
- Agent: Minoxidil
- Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients
- EFFICACY AND SAFETY OF LOW-DOSE ORAL MINOXIDIL IN THE TREATMENT OF ANDROGENETIC ALOPECIA – A LITERATURE REVIEW
- Minoxidil dose response study in female pattern hair loss patients determined to be non-responders to 5% topical minoxidil.
- Identification of the sulfotransferase iso-enzyme primarily responsible for the bio-activation of topical minoxidil.
- Rethinking Oral Minoxidil: Distinguishing the Hair-Growth Window from the Cardiovascular Threshold
- The efficacy of tretinoin gel 0.1% followed by topical minoxidil-5% in individuals with androgenetic alopecia
- Minoxidil oral en alopecias no androgénicas
- Indicações, eficácia e efeitos colaterais do Minoxidil oral: revisão integrativa
- The effect of topical minoxidil treatment on follicular sulfotransferase enzymatic activity.
- Herbal Medicines For Treatment of Androgenic Alopecia.
- Topical minoxidil effectiveness in enhancing facial aesthetics: A systematic review and meta-analysis
- Relative Efficacy of Conventional Monotherapies and Select Nonconventional, Over‐the‐Counter Products for Male Androgenetic Alopecia: A Network Meta‐Analysis Study
- Comparative Efficacy of Oral Minoxidil and Topical Minoxidil in Treating Androgenetic Alopecia: A Systematic Review and Meta-Analysis